Atomfair Brainwave Hub: SciBase II / Artificial Intelligence and Machine Learning / AI-driven drug discovery and synthesis

AI-driven drug discovery and synthesis

Showing 1-12 of 245 articles

Automated retrosynthesis strategies for accelerating drug discovery in rare disease research

Enhancing CRISPR-Cas9 precision with epigenetic reprogramming for targeted gene silencing

Optimizing drug crystallization through solvent selection engines for polymorph control

For senolytic drug discovery targeting mitochondrial dysfunction in aging cells

During circadian rhythm minima: leveraging low-activity phases for targeted cancer therapy

Exploring the role of gut microbiome ecosystems in neurodegenerative disease progression

Targeting prion disease reversal through engineered CRISPR-Cas13 systems

Automated retrosynthesis for accelerated drug discovery using quantum-inspired algorithms

Targeting cellular senescence with senolytic drugs to extend human healthspan

Targeting prion disease reversal via CRISPR-Cas13 RNA editing

Targeting prion disease reversal with CRISPR-based gene therapy approaches

Integrating neutrino physics with medical imaging for advanced tumor detection techniques